Samsca® Approved in Japan as World's First Drug Therapy for ADPKD, a Rare …
Samsca® Approved in Japan as World's First Drug Therapy for ADPKD, a Rare …
Otsuka Pharmaceutical Co. has become the first company in the world to obtain regulatory approval for a pharmacological treatment of autosomal dominant polycystic kidney disease (ADPKD). Samsca® (generic name: tolvaptan) has been approved in Japan …
Read more on Pharmaceutical Processing
Endocyte stock nearly doubles on cancer drug news
NEW YORK — Shares of Endocyte nearly doubled in value Friday after European Union regulators said the company's drug Vynfinit should be approved as a treatment for ovarian cancer, and Endocyte said the drug helped slow the progression of lung …
Read more on USA TODAY
Related Drug Treatment News Information…